Rahan Meristem

Company Overview

Snapshot

Founded in January 1974, Rahan Meristem operates with 51–200 employees. The company specializes in plant biotechnology and propagation, notably forming a joint venture in November 2017 to breed and propagate elite cannabis clones, securing a $440,000 investment.

Business overview

Rahan Meristem is a plant biotechnology and propagation company focused on tissue culture, molecular genetics, and breeding. The company is a major producer of banana plantlets by tissue culture, with its selected clones utilized in tropical regions for export desert banana fruit production. Rahan Meristem also cultivates plantains, deciduous fruit trees, olive trees, sweet potatoes, citrus, avocados, and stevia, offering laboratory and agro-technical services including crop breeding, viral cleaning and diagnostics, DNA fingerprint analysis, and propagation of transgenic plants within the Agriculture & Food Technologies sector.

Strategic signal

In July 2020, Rahan Meristem and its partner Banarica reported success in mitigating Panama Disease after field trials in the Philippines. This demonstrates the company's ongoing commitment to addressing critical agricultural challenges through biotechnology, validating its research and development capabilities in disease resistance for key tropical crops, and signaling potential for broader market adoption of its resilient plant varieties.

Company Intelligence Q&A

What is Rahan Meristem's core business?

Rahan Meristem specializes in plant biotechnology and propagation, utilizing tissue culture, molecular genetics, and breeding to produce plantlets for tropical and subtropical fruit trees, including bananas, plantains, and citrus.

Did Rahan Meristem engage in any cannabis-related ventures?

Yes, in November 2017, Rahan Meristem formed a joint venture with Future Farm to breed and propagate elite clones of cannabis, securing a $440,000 investment for this initiative.

Has Rahan Meristem achieved success in disease mitigation for its crops?

In July 2020, Rahan Meristem and its partner Banarica reported success in mitigating Panama Disease following field trials conducted in the Philippines.

What was the outcome of the field trials with Evogene?

In September 2017, Evogene and Rahan Meristem announced positive results from second-year field trials addressing Black Sigatoka disease in bananas, with plans to utilize these results for genome editing.

Where does Rahan Meristem have international operations or presence?

Rahan Meristem has offices or operations in Costa Rica, Ecuador, Colombia, and the Philippines, in addition to its headquarters in Rosh HaNikra, Israel.